CXR Biosciences, the investigative and exploratory toxicology company, has successfully provided exploratory toxicology services to the agrochemical industry for many years. Today, CXR published a brochure describing the integrated suite of studies it has developed based on this extensive experience.
Exploratory toxicology studies are those carried out prior to selection of a development candidate. It follows that the primary aim of exploratory toxicology is to identify development candidates with the optimal toxicological properties. Additional aims include (i) to predict the toxicities likely to be seen in regulatory toxicity studies, in order to ensure that suitable mechanistic endpoints can be included in those studies, and (ii) to use toxicokinetic (TK) data (generated using CXRs microsampling approach) early in a testing program to understand the relationship between dose and systemic exposure.
CXR Biosciences has an extensive track record in exploratory toxicology, having supported the programs of leading agrochemical companies for many years. We understand the scientific and industry context in which the studies are performed, and our flexible scheduling means we can deliver quality data in the short timeframes demanded by an agrochemical research organisation.
Founded in 2001, CXR Biosciences® uses its collaborative approach and toxicological expertise to help customers large and small solve issues relating to the safety of compounds or selection of research candidates. CXR Biosciences® offers tailored preclinical services in the areas of investigative & mechanistic toxicology, exploratory & discovery toxicology and PK & metabolism. Our customers include leading pharmaceutical, agrochemical, chemical, consumer product and biotechnology companies. CXR Biosciences® is located in Dundee, Scotland, United Kingdom and is a Scottish Enterprise supported company.